文献速递脑血管病外科

脑动静脉畸形手术、手术结果与自然史的2017年批判性综述

Critical review of brain AVM surgery, surgical results and natural history in 2017.
PubMed 文献 · Acta Neurochir (Wien) · 2017-05-29

该综述批判性评估脑动静脉畸形(bAVM)手术与不干预的结局,分析偏倚以明确风险。未治疗者10年和20年累积出血风险在未出血患者约16%和29%,出血起病患者35%和45%;出血事件约42%导致新发永久神经功能缺损或死亡。Spetzler-Martin及Lawton-Young分级能良好预测手术风险,8年不良结局风险取决于畸形大小、深静脉引流和功能区位置。

要点

  • 未治疗bAVM 10年和20年累积出血风险:未出血者16%和29%,出血起病者35%和45%。
  • 出血事件约42%导致新发永久神经功能缺损或死亡。
  • 手术8年不良结局风险随bAVM大小、深静脉引流和功能区位置增加。

核心结论

  • 对于预期未来8年生活质量良好的Spetzler-Ponce A级bAVM患者,在专家中心接受手术可能优于不治疗。
  • 亟需对bAVM管理路径的结局开展持续研究。

研究设计与样本

  • 对bAVM手术与不干预结局的文献进行批判性综述,并分析偏倚对结局的影响。

主要发现

  • 未治疗bAVM诊断后10年和20年累积出血风险:未出血者约16%和29%,出血起病者约35%和45%。
  • 年化出血风险约1.8%(未破裂bAVM)和4.7%(出血起病bAVM后8年,随后按未破裂bAVM率)。
  • 出血事件总体约42%导致新发永久神经功能缺损或死亡。
  • 伴近端颅内动脉瘤(APIA)和静脉流出受限可能增加后续出血风险。
  • 年龄、妊娠、女性与出血风险增加的相关性难以支持。

临床怎么用

  • 对于Spetzler-Ponce A级bAVM且预期未来8年生活质量良好的患者,作者认为在专家中心手术可能优于不治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: An understanding of the present standing of surgery, surgical results and the role in altering the future morbidity and mortality of untreated brain arteriovenous malformations (bAVMs) is appropriate considering the myriad alternative management pathways (including radiosurgery, embolization or some combination of treatments), varying risks and selection biases that have contributed to confusion regarding management. The purpose of this review is to clarify the link between the incidence of adverse outcomes that are reported from a management pathway of either surgery or no intervention with the projected risks of surgery or no intervention. METHODS: A critical review of the literature was performed on the outcomes of surgery and non-intervention for bAVM. An analysis of the biases and how these may have influenced the outcomes was included to attempt to identify reasonable estimates of risks. RESULTS: In the absence of treatment, the cumulative risk of future hemorrhage is approximately 16% and 29% at 10 and 20 years after diagnosis of bAVM without hemorrhage and 35% and 45% at 10 and 20 years when presenting with hemorrhage (annualized, this risk would be approximately 1.8% for unruptured bAVMs and 4.7% for 8 years for bAVMs presenting with hemorrhage followed by the unruptured bAVM rate). The cumulative outcome of these hemorrhages depends upon whether the patient remains untreated and is allowed to have a further hemorrhage or is treated at this time. Overall, approximately 42% will develop a new permanent neurological deficit or death from a hemorrhagic event. The presence of an associated proximal intracranial aneurysm (APIA) and restriction of venous outflow may increase the risk for subsequent hemorrhage. Other risks for increased risk of hemorrhage (age, pregnancy, female) were examined, and their purported association with hemorrhage is difficult to support. Both the Spetzler-Martin grading system (and its compaction into the Spetzler-Ponce tiers) and Lawton-Young supplementary grading system are excellent in predicting the risk of surgery. The 8-year risk of unfavorable outcome from surgery (complication leading to a permanent new neurological deficit with a modified Rankin Scale score of greater than one, residual bAVM or recurrence) is dependent on bAVM size, the presence of deep venous drainage (DVD) and location in critical brain (eloquent location). For patients with bAVMs who have neither a DVD nor eloquent location, the 8-year risk for an unfavorable outcome increases with size (increasing from 1 cm to 6 cm) from 1% to 9%. For patients with bAVM who have either a DVD or eloquent location (but not both), the 8-year risk for an unfavorable outcome increases with the size (increasing from 1 cm to 6 cm) from 4% to 35%. For patients with bAVM who have both a DVD and eloquent location, the 8-year risk for unfavorable outcome increases with size (increasing from 1 cm to 3 cm) from 12% to 38%. CONCLUSION: Patients with a Spetzler-Ponce A bAVM expecting a good quality of life for the next 8 years are likely to do better with surgery in expert centers than remaining untreated. Ongoing research is urgently required on the outcome of management pathways for bAVM.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Morgan MK, Davidson AS, Assaad NNA, et al. Critical review of brain AVM surgery, surgical results and natural history in 2017. Acta Neurochir (Wien). 2017. PMID: 28555270. doi:10.1007/s00701-017-3217-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。